Filing Details
- Accession Number:
- 0001209191-18-060103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-28 16:03:26
- Reporting Period:
- 2018-11-27
- Accepted Time:
- 2018-11-28 16:03:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1299130 | Pacific Biosciences Of California Inc. | PACB | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222643 | Kathy Ordonez | Pacific Biosciences Of California, Inc. 1305 O'Brien Drive Menlo Park CA 94025 | Chief Commercial Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-11-27 | 25,000 | $2.90 | 68,750 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-11-27 | 25,000 | $7.54 | 43,750 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2018-11-27 | 25,000 | $0.00 | 25,000 | $2.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
350,000 | 2017-12-15 | 2027-11-15 | No | 4 | A | Direct |
Footnotes
- This sale price represents the weighted average sale price of the shares sold ranging from $7.54 to $7.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The shares subject to the option will vest in equal monthly installments over a four year period.